Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia

International Journal of Antimicrobial Agents

Volumn 36, Issue 5, 2010, Pages 436-440

  Lin, Pen Yi ^a   Chen, Hsiu Ling ^a   Huang, Chung Tsui ^a   Su, Lin Hui ^a   Chiu, Cheng Hsun ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Antimicrobial susceptibility; Bacteraemia; Biofilm; Chryseobacterium meningosepticum

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFEPIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PYROXYLIN; RIFAMPICIN;

ADULT; ADVERSE OUTCOME; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; CATHETER INFECTION; CAUSE OF DEATH; CENTRAL VENOUS CATHETER; CHRYSEOBACTERIUM MENINGOSEPTICUM; CLINICAL ARTICLE; COLONY FORMATION; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ELECTRON MICROSCOPY; FATALITY; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; INDWELLING CATHETER; INTRAVASCULAR CATHETER; LENGTH OF STAY; LONG TERM CARE; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BIOFILMS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CHRYSEOBACTERIUM; CIPROFLOXACIN; FEMALE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 77957656086     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.033     Document Type: Article

References (16)

1. Bloch K.C., Nadarajah R., Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997, 76:30-41.
2. Chiu C.H., Waddingdon M., Greenberg D., Schreckenberger P.C., Carnahan A.M. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan. Emerg Infect Dis 2000, 6:481-486.
3. Lee C.C., Chen P.L., Wang L.R., Lee H.C., Chang C.M., Lee N.Y., et al. Fatal case of community-acquired bacteremia and necrotizing fasciitis caused by Chryseobacterium meningosepticum: case report and review of the literature. J Clin Microbiol 2006, 44:1181-1183.
4. Lee C.H., Lin W.C., Chia J.H., Su L.H., Chien C.C., Mao A.H., et al. Community-acquired osteomyelitis caused by Chryseobacterium meningosepticum: case report and literature review. Diagn Microbiol Infect Dis 2008, 60:89-93.
5. Lin P.Y., Chu C., Su L.H., Huang C.T., Chang W.Y., Chiu C.H. Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients. J Clin Microbiol 2004, 42:3353-3355.
6. Pokrywka M., Viazanko K., Medvick J., Knabe S., McCool S., Pasculle A.W., et al. A Flavobacterium meningosepticum outbreak among intensive care patients. Am J Infect Control 1993, 21:139-145.
7. Wu V.C., Tsai T.J., Wang R., Hsueh P.R. Peritonitis caused by Chryseobacterium meningosepticum in a patient undergoing continuous ambulatory peritoneal dialysis. J Formos Med Assoc 2003, 102:270-272.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI; 2007.
9. O'Toole G.A., Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998, 28:449-461.
10. Rodríguez-Baño J., Martí S., Soto S., Fernández-Cuenca F., Cisneros J.M., Pachón J., et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008, 14:276-278.
11. Friedman L., Kolter R. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol Microbiol 2004, 51:675-690.
12. Ko W.C., Lee H.C., Chiang S.R., Yan J.J., Wu J.J., Lu C.L., et al. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain. J Antimicrob Chemother 2004, 53:393-395.
13. Abrahamsen T.G., Finne P.H., Lingaas E. Flavobacterium meningosepticum infections in a neonatal intensive care unit. Acta Paediatr Scand 1989, 78:51-55.
14. Brown R.B., Phillips D., Barker M.J., Pieczarka R., Sands M., Teres D. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B. Am J Infect Control 1989, 17:121-125.
15. Fraser S.L., Jorgensen J.H. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997, 41:2738-2741.
16. Kirby J.T., Sader H.S., Walsh T.R., Jones R.N. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004, 42:445-448.